Cochrane Abstracts
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis: Cochrane systematic review
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Potentiators (specific Therapies for Class III and IV Mutations) for Cystic Fibrosis: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437357/all/Potentiators__specific_therapies_for_class_III_and_IV_mutations__for_cystic_fibrosis:_Cochrane_systematic_review. Accessed 23 January 2021.
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437357/all/Potentiators__specific_therapies_for_class_III_and_IV_mutations__for_cystic_fibrosis:_Cochrane_systematic_review. Accessed January 23, 2021.
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis: Cochrane systematic review. In Cochrane Abstracts Retrieved January 23, 2021, from https://evidence.unboundmedicine.com/evidence/view/Cochrane/437357/all/Potentiators__specific_therapies_for_class_III_and_IV_mutations__for_cystic_fibrosis:_Cochrane_systematic_review
Potentiators (specific Therapies for Class III and IV Mutations) for Cystic Fibrosis: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2021 January 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437357/all/Potentiators__specific_therapies_for_class_III_and_IV_mutations__for_cystic_fibrosis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis: Cochrane systematic review
ID - 437357
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437357/all/Potentiators__specific_therapies_for_class_III_and_IV_mutations__for_cystic_fibrosis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
